# AndraValvulotome Post-Market Study

> **NCT04815473** · NA · SUSPENDED · sponsor: **Andramed GmbH** · enrollment: 59 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **PROCEDURE:** Valvulotomy

## Key facts

- **NCT ID:** NCT04815473
- **Lead sponsor:** Andramed GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-04-28
- **Primary completion:** 2022-05-30
- **Final completion:** 2023-12
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** The number of evaluated valves were achieved.
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815473, "AndraValvulotome Post-Market Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04815473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*